Kollenburg L, Kurt E, Mulleners W, Abd-Elsayed A, Yazdi C, Schatman M
Curr Pain Headache Rep. 2024; 28(10):1015-1034.
PMID: 38907793
DOI: 10.1007/s11916-024-01271-1.
Brandt R, Wilbrink L, de Coo I, Haan J, Mulleners W, Huygen F
EBioMedicine. 2023; 98:104895.
PMID: 38007947
PMC: 10755111.
DOI: 10.1016/j.ebiom.2023.104895.
Robblee J
Front Neurol. 2023; 14:1263535.
PMID: 37830088
PMC: 10565861.
DOI: 10.3389/fneur.2023.1263535.
Kwon J, Han J, Choi J, Park H, Lee H
J Clin Med. 2022; 11(5).
PMID: 35268502
PMC: 8911224.
DOI: 10.3390/jcm11051411.
OConnor E, Nikram E, Grangeon L, Danno D, Houlden H, Matharu M
Cephalalgia. 2022; 42(8):715-721.
PMID: 35166160
PMC: 9218408.
DOI: 10.1177/03331024221076478.
Patient-Reported Outcomes for Migraine in the US and Europe: Burden Associated with Multiple Preventive Treatment Failures.
Ford J, Nichols R, Ye W, Tockhorn-Heidenreich A, Cotton S, Jackson J
Clinicoecon Outcomes Res. 2021; 13:647-660.
PMID: 34285524
PMC: 8286727.
DOI: 10.2147/CEOR.S304158.
Refractory migraine profile in CGRP-monoclonal antibodies scenario.
Silvestro M, Tessitore A, Scotto di Clemente F, Battista G, Tedeschi G, Russo A
Acta Neurol Scand. 2021; 144(3):325-333.
PMID: 34019304
PMC: 8453754.
DOI: 10.1111/ane.13472.
Is pituitary MRI screening necessary in cluster headache?.
Grangeon L, OConnor E, Danno D, Ngoc T, Cheema S, Tronvik E
Cephalalgia. 2021; 41(7):779-788.
PMID: 33406848
PMC: 8166405.
DOI: 10.1177/0333102420983303.
Machine phenotyping of cluster headache and its response to verapamil.
Tso A, Brudfors M, Danno D, Grangeon L, Cheema S, Matharu M
Brain. 2020; 144(2):655-664.
PMID: 33230532
PMC: 7940170.
DOI: 10.1093/brain/awaa388.
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).
Sacco S, Braschinsky M, Ducros A, Lampl C, Little P, Brink A
J Headache Pain. 2020; 21(1):76.
PMID: 32546227
PMC: 7296705.
DOI: 10.1186/s10194-020-01130-5.
New insights in post-traumatic headache with cluster headache phenotype: a cohort study.
Grangeon L, OConnor E, Chan C, Akijian L, Ngoc T, Matharu M
J Neurol Neurosurg Psychiatry. 2020; 91(6):572-579.
PMID: 32381638
PMC: 7279192.
DOI: 10.1136/jnnp-2019-322725.
Identifying and managing refractory migraine: barriers and opportunities?.
DAntona L, Matharu M
J Headache Pain. 2019; 20(1):89.
PMID: 31443629
PMC: 6734232.
DOI: 10.1186/s10194-019-1040-x.
Occipital nerve stimulation for non-migrainous chronic headaches: a systematic review protocol.
Cottin S, Gallani N, Cantin L, Prudhomme M
Syst Rev. 2019; 8(1):181.
PMID: 31331392
PMC: 6647252.
DOI: 10.1186/s13643-019-1101-x.
The neurosurgical treatment of craniofacial pain syndromes: current surgical indications and techniques.
Franzini A, Moosa S, DAmmando A, Bono B, Scheitler-Ring K, Ferroli P
Neurol Sci. 2019; 40(Suppl 1):159-168.
PMID: 30835002
DOI: 10.1007/s10072-019-03789-4.
Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study.
Bostrom A, Scheele D, Stoffel-Wagner B, Honig F, Chaudhry S, Muhammad S
J Transl Med. 2019; 17(1):53.
PMID: 30795781
PMC: 6387501.
DOI: 10.1186/s12967-019-1801-y.
Hints on Diagnosing and Treating Headache.
May A
Dtsch Arztebl Int. 2018; 115(17):299-308.
PMID: 29789115
PMC: 5974268.
DOI: 10.3238/arztebl.2018.0299.
Treatment of the Patient with Refractory Headache.
Zagami A
Curr Pain Headache Rep. 2018; 22(4):23.
PMID: 29556828
DOI: 10.1007/s11916-018-0677-5.
Managing cluster headache with sphenopalatine ganglion stimulation: a review.
Fontaine D, Santucci S, Lanteri-Minet M
J Pain Res. 2018; 11:375-381.
PMID: 29497328
PMC: 5819579.
DOI: 10.2147/JPR.S129641.
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study.
Goadsby P, de Coo I, Silver N, Tyagi A, Ahmed F, Gaul C
Cephalalgia. 2017; 38(5):959-969.
PMID: 29231763
PMC: 5896689.
DOI: 10.1177/0333102417744362.
Tolerability and Efficacy of Memantine as Add on Therapy in Patients with Migraine.
Assarzadegan F, Sistanizad M
Iran J Pharm Res. 2017; 16(2):791-797.
PMID: 28979333
PMC: 5603889.
